Published in Nucleic Acids Res on December 25, 1991
Characterization of the cobalamin (vitamin B12) biosynthetic genes of Salmonella typhimurium. J Bacteriol (1993) 3.42
The stability of Escherichia coli lacZ mRNA depends upon the simultaneity of its synthesis and translation. EMBO J (1995) 2.39
AU-rich sequences within 5' untranslated leaders enhance translation and stabilize mRNA in Escherichia coli. J Bacteriol (2005) 1.45
Decoding with the A:I wobble pair is inefficient. Nucleic Acids Res (1995) 1.40
The last RNA-binding repeat of the Escherichia coli ribosomal protein S1 is specifically involved in autogenous control. J Bacteriol (2000) 1.25
Construction and use of lambda PL promoter vectors for direct cloning and high level expression of PCR amplified DNA coding sequences. Nucleic Acids Res (1992) 0.98
Variable coordination of cotranscribed genes in Escherichia coli following antisense repression. BMC Microbiol (2006) 0.96
The Effect of an Alternate Start Codon on Heterologous Expression of a PhoA Fusion Protein in Mycoplasma gallisepticum. PLoS One (2015) 0.79
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem (1976) 903.81
Genomic sequencing. Proc Natl Acad Sci U S A (1984) 92.36
Culture medium for enterobacteria. J Bacteriol (1974) 37.59
pEMBL: a new family of single stranded plasmids. Nucleic Acids Res (1983) 19.19
Evidence for two functional gal promoters in intact Escherichia coli cells. J Biol Chem (1981) 17.42
Control of transcription termination. Annu Rev Biochem (1978) 9.24
Polypeptide chain initiation: nucleotide sequences of the three ribosomal binding sites in bacteriophage R17 RNA. Nature (1969) 8.64
Posttranscriptional regulatory mechanisms in Escherichia coli. Annu Rev Biochem (1988) 7.54
Decay of mRNA in Escherichia coli: investigation of the fate of specific segments of transcripts. Proc Natl Acad Sci U S A (1983) 6.79
Codon usage determines translation rate in Escherichia coli. J Mol Biol (1989) 5.07
Transcription and translation initiation frequencies of the Escherichia coli lac operon. J Mol Biol (1977) 4.70
Secondary structure of the ribosome binding site determines translational efficiency: a quantitative analysis. Proc Natl Acad Sci U S A (1990) 4.45
Mechanisms of mRNA decay in bacteria: a perspective. Gene (1988) 4.28
Translational control of prokaryotic gene expression. Trends Genet (1990) 2.78
The ompA 5' untranslated RNA segment functions in Escherichia coli as a growth-rate-regulated mRNA stabilizer whose activity is unrelated to translational efficiency. J Bacteriol (1990) 2.68
What constitutes the signal for the initiation of protein synthesis on Escherichia coli mRNAs? J Mol Biol (1988) 2.50
A preliminary map of genomic sites for F-attachment in Escherichia coli K12. Biochem Biophys Res Commun (1964) 2.47
Translation and mRNA decay. Mol Gen Genet (1978) 2.40
Effect of premature termination of translation on mRNA stability depends on the site of ribosome release. Proc Natl Acad Sci U S A (1987) 2.24
Processivity errors of gene expression in Escherichia coli. J Mol Biol (1990) 1.96
Changes in the half-life of ribosomal protein messenger RNA caused by translational repression. J Mol Biol (1986) 1.87
Preventing the synthesis of unused transcripts by Rho factor. Cell (1991) 1.75
Purification, structure, and properties of hybrid beta-galactosidase proteins. J Biol Chem (1983) 1.68
Inefficient translation initiation causes premature transcription termination in the lacZ gene. Cell (1986) 1.63
Escherichia coli lac operator mRNA affects translation initiation of beta-galactosidase mRNA. Nature (1979) 1.60
Functional inactivation of bacteriophage lambda morphogenetic gene in RNA. Nature (1975) 1.60
Transcription and decay of the lac messenger: role of an intergenic terminator. J Bacteriol (1991) 1.58
RNase III stimulates the translation of the cIII gene of bacteriophage lambda. Proc Natl Acad Sci U S A (1987) 1.54
Autogenous control of Escherichia coli threonyl-tRNA synthetase expression in vivo. J Mol Biol (1985) 1.53
Codon contexts from weakly expressed genes reduce expression in vivo. J Mol Biol (1989) 1.46
Stability of ribosomal protein mRNA and translational feedback regulation in Escherichia coli. Mol Gen Genet (1985) 1.32
Secondary structure as primary determinant of the efficiency of ribosomal binding sites in Escherichia coli. Nucleic Acids Res (1986) 1.18
The functional stability of the lacZ transcript is sensitive towards sequence alterations immediately downstream of the ribosome binding site. Mol Gen Genet (1987) 1.17
Intermediates in the degradation of mRNA from the lactose operon of Escherichia coli. Nucleic Acids Res (1991) 1.15
Transcription of single-copy hybrid lacZ genes by T7 RNA polymerase in Escherichia coli: mRNA synthesis and degradation can be uncoupled from translation. Nucleic Acids Res (1990) 1.13
Lack of a 5' non-coding region in Tn1721 encoded tetR mRNA is associated with a low efficiency of translation and a short half-life in Escherichia coli. Nucleic Acids Res (1991) 1.10
The differential stability of the Escherichia coli ompA and bla mRNA at various growth rates is not correlated to the efficiency of translation. Gene (1988) 1.05
Sequence changes preceding a Shine-Dalgarno region influence trpE mRNA translation and decay. J Mol Biol (1988) 1.03
Translational coupling of the two proximal genes in the S10 ribosomal protein operon of Escherichia coli. J Bacteriol (1989) 1.01
Multiple determinants of functional mRNA stability: sequence alterations at either end of the lacZ gene affect the rate of mRNA inactivation. J Bacteriol (1991) 0.99
The importance of the 5'-region in regulating the stability of sdh mRNA in Bacillus subtilis. Mol Microbiol (1990) 0.99
Translation initiation controls the relative rates of expression of the bacteriophage lambda late genes. Proc Natl Acad Sci U S A (1988) 0.97
Translational coupling varying in efficiency between different pairs of genes in the central region of the atp operon of Escherichia coli. Mol Microbiol (1991) 0.91
Interdependence of translation, transcription and mRNA degradation in the lacZ gene. J Mol Biol (1992) 3.38
[Tocolysis with nifedipine: its use in current practice]. Gynecol Obstet Fertil (2005) 3.30
The stability of Escherichia coli lacZ mRNA depends upon the simultaneity of its synthesis and translation. EMBO J (1995) 2.39
Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin-induced thrombocytopenia. Thromb Haemost (1992) 2.31
Ded1p, a DEAD-box protein required for translation initiation in Saccharomyces cerevisiae, is an RNA helicase. J Biol Chem (1999) 2.06
The C-terminal half of RNase E, which organizes the Escherichia coli degradosome, participates in mRNA degradation but not rRNA processing in vivo. Mol Microbiol (1999) 1.86
mRNAs can be stabilized by DEAD-box proteins. Nature (1994) 1.72
Use of recombinant factor VIIa in 3 patients with inherited type I Glanzmann's thrombasthenia undergoing invasive procedures. Thromb Haemost (2000) 1.71
Translation initiation in Escherichia coli: old and new questions. Mol Microbiol (1990) 1.64
Antibodies to macromolecular platelet factor 4-heparin complexes in heparin-induced thrombocytopenia: a study of 44 cases. Thromb Haemost (1995) 1.58
Practices for prevention, diagnosis and management of postpartum haemorrhage: impact of a regional multifaceted intervention. BJOG (2009) 1.56
Germ-line p53 mutations in 15 families with Li-Fraumeni syndrome. Am J Hum Genet (1995) 1.46
[The 2005-2007 Perinatality Plan: head on or headache?]. J Gynecol Obstet Biol Reprod (Paris) (2005) 1.39
Transcribing of Escherichia coli genes with mutant T7 RNA polymerases: stability of lacZ mRNA inversely correlates with polymerase speed. Proc Natl Acad Sci U S A (1995) 1.36
In the absence of translation, RNase E can bypass 5' mRNA stabilizers in Escherichia coli. J Mol Biol (1998) 1.35
Bacteriophage T7 RNA polymerase travels far ahead of ribosomes in vivo. J Bacteriol (1992) 1.35
Non-canonical mechanism for translational control in bacteria: synthesis of ribosomal protein S1. EMBO J (2001) 1.26
The last RNA-binding repeat of the Escherichia coli ribosomal protein S1 is specifically involved in autogenous control. J Bacteriol (2000) 1.25
Control of Escherichia coli lysyl-tRNA synthetase expression by anaerobiosis. J Bacteriol (1991) 1.18
The selection and characterisation of two novel mutations in the overlapping promoters of the Escherichia coli galactose operon. Gene (1984) 1.18
Transcription of single-copy hybrid lacZ genes by T7 RNA polymerase in Escherichia coli: mRNA synthesis and degradation can be uncoupled from translation. Nucleic Acids Res (1990) 1.13
Bacteriophage T7 protein kinase phosphorylates RNase E and stabilizes mRNAs synthesized by T7 RNA polymerase. Mol Microbiol (2001) 1.09
The use of a tRNA as a transcriptional reporter: the T7 late promoter is extremely efficient in Escherichia coli but its transcripts are poorly expressed. Nucleic Acids Res (1994) 1.07
[Efficiency of magnesium sulfate for the prevention of eclampsia in women with preeclampsia]. Gynecol Obstet Fertil (2010) 1.07
The relation between translation and mRNA degradation in the lacZ gene. Biochimie (1991) 1.07
Mouse kidney and submaxillary gland renin genes differ in their 5' putative regulatory sequences. Proc Natl Acad Sci U S A (1984) 1.06
Risk of cervical stenosis after large loop excision or laser conization. Obstet Gynecol (1996) 1.04
Translation inhibitors stabilize Escherichia coli mRNAs independently of ribosome protection. Proc Natl Acad Sci U S A (1998) 1.02
T7 RNA polymerase studied by force measurements varying cofactor concentration. Biophys J (2008) 1.01
[Postpartum haemorrhage: recommendations for clinical practice by the CNGOF (December 2004)]. Gynecol Obstet Fertil (2005) 0.99
[Consequences and treatment of cervical stenoses after laser conization or loop electrosurgical excision]. J Gynecol Obstet Biol Reprod (Paris) (1997) 0.98
Tautomerism of purines. I. N(7)H in equilibrium N(9)H equilibrium in adenine. J Am Chem Soc (1975) 0.97
Regulated expression of the Ren-2 gene in transgenic mice derived from parental strains carrying only the Ren-1 gene. EMBO J (1987) 0.97
Point mutations that affect translation initiation in the Escherichia coli gal E gene. J Mol Biol (1985) 0.97
Prenatal sonographic diagnosis of skeletal dysplasias. A report of 47 cases. Ann Genet (2001) 0.95
Letter: Experimental model for von Willebrand's disease. Nature (1973) 0.95
Autoregulation allows Escherichia coli RNase E to adjust continuously its synthesis to that of its substrates. Mol Microbiol (2001) 0.95
Maternal outcome of gestational diabetes mellitus. Diabetes Metab (2010) 0.93
Pregnancy-associated thrombocytopenia revisited: assessment and follow-up of 50 cases. Blood (1998) 0.92
The low processivity of T7 RNA polymerase over the initially transcribed sequence can limit productive initiation in vivo. J Mol Biol (1997) 0.92
On the mechanism of inhibition of phage T7 RNA polymerase by lac repressor. J Mol Biol (1998) 0.92
Spontaneous regression of fetal pulmonary sequestration. Ultrasound Obstet Gynecol (1995) 0.90
Screening histories of incidence cases of cervical cancer and high grade SIL. A comparison. Acta Cytol (1997) 0.89
Myocardial infarction occurring in a case of acquired haemophilia during the treatment course with recombinant activated factor VII. Thromb Haemost (2002) 0.88
Rupture of the scarred uterus. Acta Obstet Gynecol Scand (2007) 0.87
[Inflammatory bowel disease and pregnancy: report of 76 cases and review of the literature]. J Gynecol Obstet Biol Reprod (Paris) (2005) 0.87
Culture conditions differentially affect the translation of individual Escherichia coli mRNAs. J Mol Biol (1992) 0.86
Antibodies against synthetic oligopeptides allow identification of the mRNA-maturase encoded by the second intron of the yeast cob-box gene. EMBO J (1984) 0.86
Successful long-term replacement therapy with FXIII concentrate (Fibrogammin(®) P) for severe congenital factor XIII deficiency: a prospective multicentre study. J Thromb Haemost (2011) 0.85
Analysis of promoter and enhancer cell type specificities and the regulation of immunoglobulin gene expression. Gene (1986) 0.85
[Ogilvie's syndrome following cesarean section: Just think! Report of two cases and review of the literature]. J Gynecol Obstet Biol Reprod (Paris) (2011) 0.85
Tautomerism in cytosine and 3-methylcytosine. A thermodynamic and kinetic study. J Am Chem Soc (1976) 0.84
Mutations in the fibrinogen aalpha gene account for the majority of cases of congenital afibrinogenemia. Blood (2000) 0.84
[Obstetrical management in the event of persistent or worsening postpartum hemorrhage despite initial measures]. J Gynecol Obstet Biol Reprod (Paris) (2004) 0.84
[Prevention and early management of immediate postpartum haemorrhage: policies in six perinatal networks in France]. J Gynecol Obstet Biol Reprod (Paris) (2008) 0.84
[Medical treatment of early spontaneous miscarriages: a prospective study of outpatient management using misoprostol]. J Gynecol Obstet Biol Reprod (Paris) (2004) 0.83
Antenatal sonographic features of aneurysmal dilatation of a vitelline vein. Ultrasound Obstet Gynecol (2007) 0.83
Regulatory elements involved in the bidirectional activity of an immunoglobulin promoter. Nucleic Acids Res (1989) 0.83
[Survey of the practice of cervical ripening and labor induction in France]. J Gynecol Obstet Biol Reprod (Paris) (2003) 0.83
Inter-laboratory variability of the measurement of low titer factor VIII:C inhibitor in haemophiliacs: improvement by the Nijmegen modification of the Bethesda assay and the use of common lyophilized plasmas. Haemophilia (1999) 0.83
[Antenatal diagnosis and management of vein of Galen aneurysm: review illustrated by a case report]. J Gynecol Obstet Biol Reprod (Paris) (2005) 0.83
Cervical cancer screening with cervicography and cytology. Eur J Obstet Gynecol Reprod Biol (1995) 0.82
Longitudinal analysis of platelet count and volume in normal pregnancy. Thromb Haemost (1997) 0.82
Screening primiparous women and newborns for fetal/neonatal alloimmune thrombocytopenia: a prospective comparison of effectiveness and costs. Immune Thrombocytopenia Working Group. Am J Perinatol (1996) 0.82
[Management of the HELLP syndrome]. Gynecol Obstet Fertil (2008) 0.82
Vitamin-K deficiency in the newborn. Lancet (1979) 0.82
An analysis of the factors involved in the diagnostic accuracy of colposcopically directed biopsy. Acta Obstet Gynecol Scand (1997) 0.82
Mechanism of allosteric activation of glycogen phosphorylase probed by the reactivity of essential arginyl residues. Physicochemical and kinetic studies. Biochemistry (1980) 0.82
Clinical features in 36 patients homozygous for the ARG 506-->GLN factor V mutation. Thromb Haemost (1997) 0.81
Solvent effects on allosteric equilibria: stabilization of T and R conformations of Escherichia coli aspartate transcarbamylase by organic solvents. Biochemistry (1984) 0.81
[From the impact of French guidelines to reduce episiotomy's rate]. J Gynecol Obstet Biol Reprod (Paris) (2011) 0.81
Corticosteroid therapy for conservative management in marginally-viable pregnancy complicated by HELLP syndrome. Eur J Obstet Gynecol Reprod Biol (1999) 0.81
Effects of a single bolus of urokinase in patients with life-threatening pulmonary emboli: a descriptive trial. Circulation (1984) 0.81
[Magnesium sulphate and severe preeclampsia: its use in current practice]. J Gynecol Obstet Biol Reprod (Paris) (2005) 0.81
The Ser 460 to Pro substitution of the protein S alpha (PROS1) gene is a frequent mutation associated with free protein S (type IIa) deficiency. Blood (1995) 0.81
Protein A sepharose immunoadsorption: immunological and haemostatic effects in two cases of acquired haemophilia. Br J Haematol (2001) 0.81
Prenatal diagnosis of Walker-Warburg syndrome in three sibs. Am J Med Genet (1998) 0.81
Stabilization of a phosphorylase b active conformation by hydrophobic solvents. FEBS Lett (1978) 0.80
Maternal thrombocytopenia during pregnancy: diagnosis and etiology. Semin Thromb Hemost (1995) 0.80
Renin-promoter SV40 large T-antigen transgenes induce tumors irrespective of normal cellular expression of renin genes. Oncogene Res (1989) 0.80
Multi-therapeutic approach to manage delivery in an alloimmunized patient with type 3 von Willebrand disease. J Thromb Haemost (2003) 0.79
[Iron deficiency anemia and pregnancy. Prevention and treatment]. J Gynecol Obstet Biol Reprod (Paris) (2011) 0.79
The lacZ mRNA can be stabilised by the T7 late mRNA leader in E coli. Biochimie (1996) 0.79
Multiplate whole blood impedance aggregometry: a new tool for von Willebrand disease. J Thromb Haemost (2011) 0.79
The use of a tRNA as a transcriptional reporter: the T7 late promoter is extremely efficient in Escherichia coli but its transcripts are poorly expressed. Nucleic Acids Res (1994) 0.78
[Sixty-nine consecutive cases of eclampsia: prodromes and circumstances]. J Gynecol Obstet Biol Reprod (Paris) (2011) 0.78
[Management of the first trimester miscarriages]. Gynecol Obstet Fertil (2009) 0.78
[Severe neonatal thrombopenia. Analysis of the etiologic data on 64 cases]. Arch Fr Pediatr (1984) 0.78
Colposcopy and directed biopsy reliability during pregnancy: a cohort study. Eur J Obstet Gynecol Reprod Biol (1995) 0.78
Isolation of DNA-protein complexes based on streptavidin and biotin interaction. Eur J Biochem (1987) 0.78
[Laparoscopic management of pelvic mass in pregnancy]. J Gynecol Obstet Biol Reprod (Paris) (2006) 0.78
[Anesthesiologists at the initial stage of postpartum hemorrhage]. J Gynecol Obstet Biol Reprod (Paris) (2004) 0.78
Prevalence of antiphospholipid-related antibodies in unselected patients with history of venous thrombosis. Blood Coagul Fibrinolysis (1998) 0.77
[Management of pregnant women with abnormal cervical smears. A series of 146 patients]. J Gynecol Obstet Biol Reprod (Paris) (1996) 0.77
Intravenous gammaglobulin, thrombocytopenia, and the acquired immunodeficiency syndrome. Ann Intern Med (1985) 0.77